Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar 14;13(2):159-65.
doi: 10.1021/co1000508. Epub 2011 Feb 21.

Solution-phase parallel synthesis and SAR of homopiperazinyl analogs as positive allosteric modulators of mGlu₄

Yiu-Yin Cheung  1 , Rocio Zamorano, Anna L Blobaum, C David Weaver, P Jeffrey Conn, Craig W Lindsley, Colleen M Niswender, Corey R Hopkins
Affiliations

Solution-phase parallel synthesis and SAR of homopiperazinyl analogs as positive allosteric modulators of mGlu₄

Yiu-Yin Cheung et al. ACS Comb Sci. .

Abstract

Using a functional high-throughput screening (HTS) and subsequent solution-phase parallel synthesis approach, we have discovered a novel series of positive allosteric modulators for mGlu₄, a G-protein coupled receptor. This series is comprised of a homopiperazine central core. The solution-phase parallel synthesis and SAR of analogs derived from this series will be presented. This series of positive allosteric modulators of mGlu₄ provide critical research tools to further probe the mGlu₄-mediated effects in Parkinson's disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of PHCCC, 1, and other recently reported mGlu4 PAMs, 2–9.
Figure 2
Figure 2
Areas of SAR Exploration of VU0105737, 9.
Scheme 1
Scheme 1
Scheme 2
Scheme 2
Synthetic procedure for the initial homopiperazine analogs, 20a–j.
Scheme 3
Scheme 3
See this image and copyright information in PMC

References

    1. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AHV, Halliday G. Missing pieces in the Parkinson's disease puzzle. Nat. Med. 2010;16:653–661. - PubMed
    1. Schapira AHV, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B, Hengerer B, Hirsch E, Jenner P, Le Novére N, Obeso JA, Schwarzchild MA, Spampinato U, Davidai G. Novel pharmacological targets for the treatment of Parkinson's disease. Nature Rev. Drug Discov. 2006;5:845–854. - PubMed
    1. Jankovic J. Parkinson's disease therapy: treatment of early and late disease. Chin. Med. J. 2001;114:227–234. - PubMed
    1. Conn PJ, Christopoulos A, Lindsley CW. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nature Rev. Drug. Dis. 2009;8:41–54. - PMC - PubMed
    1. Schoepp DD. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharm. Expt. Ther. 2001;299:12–20. - PubMed

Publication types

MeSH terms

Substances